Skip to content
Open access

Diet-dependent gut microbiota remodeling by pasteurized Akkermansia muciniphila, specialized pro-resolving mediators, and B vitamins in mice

Aug 2026 · Journal of Translational Medicine · Vol 24 · 0 citations · 89 references
Medicine

TL;DR

All interventions attenuated key features of HFD-induced metabolic dysfunction, particularly adiposity and lipid dysregulation, whereas improvements in glucose homeostasis remained limited, indicating mitigation of the metabolic phenotype.

Abstract

A high-fat diet induces alterations in gut microbiota composition, which can be partially or completely restored through targeted dietary interventions. The present study investigated the effects of pasteurised Akkermansia muciniphila, Specialized Pro-resolving Mediators (SPMs), and B vitamins on host metabolism and gut microbiota composition in C57BL/6J mice under standard (SD) or high-fat (HFD) conditions. Morphometric parameters, such as body weight, waist circumference, BMI, epididymal fat mass, and metabolic parameters, such as total cholesterol, HDL, LDL, VLDL, triglycerides, TG/HDL-C ratio, and glycemia, were determined. Gut microbiota composition was characterized by 16SrRNA gene sequencing, and microbial alpha-diversity was assessed using Shannon and Simpson indices. Differences in amplicon sequence variants (ASVs) were analysed. All interventions attenuated key features of HFD-induced metabolic dysfunction, particularly adiposity and lipid dysregulation, whereas improvements in glucose homeostasis remained limited, indicating mitigation of the metabolic phenotype. HFD induced a robust remodeling of the gut microbiota, including an increased Firmicutes:Bacteroidota ratio, enrichment of Lachnospiraceae, and depletion of SCFA-producing taxa and fiber-degrading bacteria, without consistent effects on alpha-diversity. Under SD, A. muciniphila exerted extensive changes, associated with taxa previously linked to SCFA production, but, under HFD, its effects were attenuated and constrained by dietary conditions. SPMs and B vitamins induced selective changes in bacterial groups associated with carbohydrate metabolism and microbial cross-feeding networks. Under HFD, no significant effects of SPMs were detected; in the contrast, B vitamins promoted changes in bacterial groups involved in complex carbohydrate degradation and fermentation processes. Together, these findings support a model in which the three interventions, whose effects are shaped by dietary context, act as modulators rather than reshapers of microbial communities. Importantly, they appear to influence the gut microbiota through distinct and non-overlapping mechanisms, rather than inducing uniform patterns of microbial modulation.

Read PDF

Similar papers

Open access Sep 2026

Gut dysbiosis induced by sunflower oil-based sucrose-free high-fat diet leads to steatohepatitis

High-fat diets (HFDs) are known to disrupt gut microbiota, contributing to obesity, inflammation, and metabolic disorders. Although sucrose is a known driver of gut dysbiosis, the microbiome alterations caused by sucrose-free fish oil and sunflower oil-based HFDs remain unclear. To investigate how sucrose-free sunflowe...

F. Bahman, M. Z. Malik, S. Kochumon et al. · 0 citations
Sep 2026

Ganoderma lucidum spore oil ameliorates high-fat-diet-induced hepatic lipid metabolism disorder by modulation of the gut microbiota.

BACKGROUND Obesity is a major global public health challenge. A high-fat diet (HFD) is a key contributing factor, closely associated with gut microbiota dysbiosis. Although immunomodulatory effects of Ganoderma lucidum spore oil (GLSO) have been reported, its role in lipid metabolism disorders and its interaction with...

Jia-Ning Zhang, Yuan-Lan Yang, Xin-Yi Zhou et al. · 0 citations
Sep 2026

Tetramethylpyrazine ameliorates metabolic dysfunction-associated steatohepatitis by modulating gut microbiota dysbiosis and restoring intestinal barrier integrity.

BACKGROUND AND PURPOSE This study investigated the therapeutic effects and gut-liver axis-related mechanisms of tetramethylpyrazine (TMP) in metabolic dysfunction-associated steatohepatitis (MASH). EXPERIMENTAL APPROACH Male C57BL/6 mice were fed a methionine- and choline-deficient (MCD) diet for 6 weeks to establish...

Xiao-Li He, Linzhang Zhang, Ya-Di Zhu et al. · 0 citations
Aug 2026

Arbutin Reshapes Intestinal Microbiota to Ameliorate Lipid Metabolic Dysfunction and Inflammation.

Gut microbial dysbiosis drives obesity-related metabolic disorders. This study investigated whether arbutin, a phenolic glycoside, alleviates obesity via gut microbiota modulation. In obese mice, arbutin reduced body weight, improved glucose and lipid profiles, suppressed adipogenic and inflammatory gene expression, an...

Cun-Hua Zhao, Jia-Jia Li, Li-Tuo Li et al. · 0 citations
Open access Aug 2026

Agaro-Oligosaccharides Modulate Gut Microbiota to Improve Lipid Metabolism in Obesity Model Rats.

Obesity is a global health concern, prompting extensive research to identify food components with potential anti-obesity properties. Agaro-oligosaccharides (AOS) have been reported to have anti-obesity effects; however, the precise mechanisms underlying these effects, particularly in relation to the gut microbial metab...

Kento Kuramitsu, Y. Kitaura, Koji Karasawa et al. · 0 citations
Sep 2026

Oligosaccharides from Dendrobium officinale Ameliorate Metabolic Dysfunction in db/db Mice by Modulating Gut Microbiota, Short-Chain Fatty Acid Production, and Intestinal Barrier Integrity

Functional oligosaccharides have attracted attention as dietary interventions for type 2 diabetes mellitus (T2DM). However, the effects of oligosaccharides derived from Dendrobium officinale (DOO1) in T2DM remain unclear. This study evaluated the effects of DOO1 on metabolic parameters, gut microbiota, short-chain fa...

Yuan Li, Tong Gao, Zi-Ying Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.